A Phase 1, Multiple Ascending Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fentanyl Sublingual Spray in Opioid Naive Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2016
At a glance
- Drugs Fentanyl (Primary) ; Fentanyl
- Indications Cancer pain
- Focus Pharmacokinetics
- Sponsors INSYS Therapeutics, Inc
- 28 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 08 Jan 2016 New trial record